Live Longer & Healthier

Neurodegenerative diseases like Alzheimer’s can begin 10+ years before symptoms emerge. We use AI-assisted quantitative MRI as well as biomarker and genome testing to assess your risks and monitor changes in specific brain regions over time—allowing us to intervene proactively.

Narrowing of the blood vessels in the neck and brain can cause progressive but silent micro-strokes, affecting over a third of adults by age 70, and significantly increasing dementia risk. We use noninvasive neurovascular imaging (MRI/MRA) which is extremely sensitive at detecting narrowed vessels as well as aneurysms—which are often highly treatable.

Lung cancer is the leading cause of cancer death, with over 50% of cases found at Stage 4, with a survival rate less than 10%. We use regular low-dose lung CTs to detect abnormalities early, when surgery can still completely remove the cancer and the survival rate is 90%. We also monitor for a variety of chronic conditions like COPD, helping protect long-term lung function.

Colon cancer is the 2nd deadliest cancer in the US, and in addition to regular colonoscopy, we improve early detection with regular non-invasive cancer DNA testing.

Pancreatic cancer is the 3rd deadliest cancer, and is almost always at stage 4 by the time symptoms develop. We can find it early using cancer blood testing as well as focused MRI.

Fatty liver disease is an exploding silent pandemic, and can develop even in "healthy" people at normal body weight. We now know it is a core driver of metabolic health, cirrhosis, and early mortality. We are able to quantify liver health and fat distribution in 30 seconds with a focused MRI, and bring your liver back into balance before permanent damage occurs.

Kidney and bladder cancers are often slow growing and curable if caught early, however there is no insurance covered screening test available, and most are not found until late stage. We assess your genetic risk for kidney disease, and screen for cancers with focused MRI and cancer blood testing.

Prostate cancer is highly treatable when detected early but remains the second-leading cause of cancer death among men. Ovarian cancer is frequently diagnosed late, contributing to a survival rate below 50%. We utilize multi-parametric MRI, advanced lab testing, and genomic screening to detect these cancers early.